FDA Proposes Ending Use of Oral Phenylephrine as OTC Monograph Nasal Decongestant Active Ingredient After Extensive Review
www.fda.gov
FDA is proposing to end the use of oral phenylephrine for the temporary relief of nasal congestion because the agency determined it is not effective.